Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation
安罗替尼可能对不携带BRAFv600e突变的乳头状颅咽管瘤具有治疗作用。
期刊:Acta Neuropathologica Communications
影响因子:5.7
doi:10.1186/s40478-025-01972-7
Ainiwan, Yilamujiang; Li, Haomin; Zheng, Yongjia; Wei, Songtao; Peng, Junxiang; Nie, Jing; Mao, Chaofu; Chen, Kunxiang; Chen, Siyuan; Liu, Ningyuan; Li, Can; Chen, Yan; Qu, Shanqiang; Wang, Yunji; Zhou, Mingfeng; Mao, Jian; Mei, Fen; Chen, Jingting; Song, Qiancheng; Qi, Songtao; Pan, Jun
